Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Clin Cancer Res. 2016 May 16;22(23):5755–5764. doi: 10.1158/1078-0432.CCR-16-0148

Table 2.

Univariate analysis of clinicopathological features.

Variable Unit Reference HR (95% CI) p-value*
Age 10 year 0.93 (0.63,1.39) 0.74
FULV. dose 500 vs. 250mg 0.95 (0.79,1.15) 0.63
ER levels 1-unit increase in Allred
score**
1.00 (0.92,1.08) 0.92
PR levels ≥6 / <6 Allred
score
0.59 (0.38,0.91) 0.016
HER2 status 3 / 0–2 IHC 1.91 (1.04,3.52) 0.037
Ki67 10% increase 1.13 (0.99,1.29) 0.064
*

Hazard ratio (HR) and 95% confidence interval (CI) are from a univariate Cox model, p-values are from a Wald-type hypothesis test.

**

ER was not significant (p > 0.5) for all possible cutpoints in Allred score.